Operating Lease, Right-of-Use Asset of Inmune Bio, Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Inmune Bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Inmune Bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,064,000, a 218% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Inmune Bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,064,000 +$729,000 +218% 30 Sep 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 $374,000 +$11,000 +3% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $278,000 -$111,000 -29% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $307,000 -$107,000 -26% 31 Dec 2024 10-Q 30 Oct 2025 2025 Q3
Q3 2024 $335,000 -$109,000 -25% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 $363,000 -$105,000 -22% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $389,000 -$96,000 -20% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $414,000 -$93,000 -18% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $444,000 -$85,000 -16% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $468,000 -$182,000 -28% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $485,000 -$196,000 -29% 31 Mar 2023 10-Q 03 May 2023 2023 Q1
Q4 2022 $507,000 -$219,000 -30% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $529,000 +$401,000 +313% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $650,000 +$513,000 +374% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $681,000 +$534,000 +363% 31 Mar 2022 10-Q 05 May 2022 2022 Q1
Q4 2021 $726,000 +$570,000 +365% 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $128,000 -$37,388 -23% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $137,000 -$37,649 -22% 30 Jun 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 $147,000 -$35,680 -20% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $156,000 -$35,543 -19% 31 Dec 2020 10-K 03 Mar 2022 2021 FY
Q3 2020 $165,388 -$33,828 -17% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $174,649 -$34,585 -17% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $182,680 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $191,543 31 Dec 2019 10-K 04 Mar 2021 2020 FY
Q3 2019 $199,216 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $209,234 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.